GLP-1 & incretin therapies · Live ClinicalTrials.gov data

Mazdutide clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 mazdutide trials on ClinicalTrials.gov by enrolment, 5 of them actively recruiting. The next phase 3 primary completion among them is expected Dec 2026. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

11

Phase 3 trials

5

Actively recruiting

Dec 2026

Next phase 3 primary completion

8,247

Participants across trials

Innovent Biologics (Suzhou) Co. Ltd.

Lead sponsor by trial count

mazdutide (16)9 active20212031
mazdutide
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingNot yet recruitingCompleted
'21
'22
'23
'24
'25
'26
'27
'28
'29
'30
'31
mazdutide
A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese SubjectsP2
A Study of IBI362 in Chinese Patients With Type 2 DiabetesP2
A Study of IBI362 in Participants With Obesity or OverweightP3
A Study of IBI362 in Participants With Type 2 DiabetesP3
A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and ExerciseP3
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightP2
A Study of IBI362 9 mg in Chinese Adults With ObesityP3
A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and ObesityP3
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use DisorderP2
A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)P3
A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2P3
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)P3
A Study of IBI362 in Chinese Adolescents With Obesity or OverweightP3
A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorP3
Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/ObesityP3
QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic NephropathyP4

Upcoming readouts

7 ahead · mazdutide

Select a trial to load its full ClinicalTrials.gov record.

Key mazdutide trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

Track mazdutide with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track mazdutide

FAQ

How many clinical trials are running for mazdutide?
ClinicalTrials.gov lists more than 16 phase 2–4 mazdutide trials. This page tracks the 16 largest by enrolment: 4 phase 2, 11 phase 3, and 1 phase 4 among them, with 5 actively recruiting. Updated daily.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare mazdutide against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.